SG10201810450QA - Organoarsenic compounds and methods for the treatment of cancer - Google Patents
Organoarsenic compounds and methods for the treatment of cancerInfo
- Publication number
- SG10201810450QA SG10201810450QA SG10201810450QA SG10201810450QA SG10201810450QA SG 10201810450Q A SG10201810450Q A SG 10201810450QA SG 10201810450Q A SG10201810450Q A SG 10201810450QA SG 10201810450Q A SG10201810450Q A SG 10201810450QA SG 10201810450Q A SG10201810450Q A SG 10201810450QA
- Authority
- SG
- Singapore
- Prior art keywords
- cancer
- treatment
- methods
- organoarsenic compounds
- organoarsenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
OrganoarsenicCompounds And Methods For The Treatment Of Cancer A method for treating a lymphoma selected from non-Hodgkin's and Hodgkin's lymphoma comprising administering an organoarsenic compound having a structure of the formula (I) wherein X is S or Se and Rl and R are independently Cl-30alkyl (R3, R3', R4, R5, W and "n" are as defined in claim 1 ) in particular where the compound is S- dimethylarsinoglutathione, N-(2-S-dimethylarsinothiopropionyl)glycine, 2- amino-3- (dimethylarsino)thio-3-methylbutanoic acid, S-dimethylarsino-thiosuccinic acid or S- dipropylarsino-1 - thioglycerol. (I) W -41-
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18951108P | 2008-08-20 | 2008-08-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201810450QA true SG10201810450QA (en) | 2018-12-28 |
Family
ID=41707414
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201810450QA SG10201810450QA (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
| SG10201810449XA SG10201810449XA (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
| SG10201403869TA SG10201403869TA (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201810449XA SG10201810449XA (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
| SG10201403869TA SG10201403869TA (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US20110269697A1 (en) |
| EP (2) | EP2321012B1 (en) |
| JP (5) | JP5933896B2 (en) |
| KR (3) | KR20170103023A (en) |
| CN (2) | CN102149432A (en) |
| AU (1) | AU2009282972A1 (en) |
| BR (1) | BRPI0918407A2 (en) |
| CA (1) | CA2734650A1 (en) |
| DK (2) | DK2321012T3 (en) |
| ES (2) | ES2901426T3 (en) |
| HK (2) | HK1254607A1 (en) |
| IL (1) | IL211153A0 (en) |
| MX (1) | MX2011001800A (en) |
| NZ (1) | NZ591181A (en) |
| PT (2) | PT2321012T (en) |
| RU (1) | RU2534606C2 (en) |
| SG (3) | SG10201810450QA (en) |
| WO (1) | WO2010021928A1 (en) |
| ZA (1) | ZA201101216B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015085208A1 (en) * | 2013-12-05 | 2015-06-11 | Solasia Pharma K.K. | Compounds and methods for the treatment of cancer |
| CN104151397A (en) * | 2014-07-03 | 2014-11-19 | 北京大学 | Novel thiabicyclo organic arsenide compound and synthesis method thereof, as well as application in anti-tumor field |
| JP6413969B2 (en) * | 2015-07-29 | 2018-10-31 | 住友金属鉱山株式会社 | Dispersion for forming solar shading body and solar shading body using the dispersion |
| JPWO2019220961A1 (en) * | 2018-05-18 | 2020-05-28 | ソレイジア・ファーマ株式会社 | Crystalline form of darinaparcin alkali metal salt and/or inorganic acid addition salt and preparation thereof |
| CN113408945B (en) * | 2021-07-15 | 2023-03-24 | 广西中烟工业有限责任公司 | Method and device for detecting purity of flue-cured tobacco, electronic equipment and storage medium |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US234972A (en) | 1880-11-30 | William ennis | ||
| US761900A (en) | 1904-03-05 | 1904-06-07 | Newton Jefferson Norman | Flux compound. |
| US2349729A (en) | 1940-08-24 | 1944-05-23 | Parke Davis & Co | Therapeutic arsenic preparation |
| EP1374875A3 (en) | 1997-10-15 | 2004-01-07 | Polarx Biopharmaceuticals, Inc. | Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| JP2001522799A (en) | 1997-11-10 | 2001-11-20 | メモリアル スローン−ケタリング キャンサー センター | Method for producing arsenic trioxide preparation and method for treating cancer using arsenic trioxide or melarsoprol |
| CN1233476A (en) | 1998-04-24 | 1999-11-03 | 陆道培 | Medicine for treating acute leukemia, and method for preparing same |
| EP1002537A1 (en) | 1998-10-30 | 2000-05-24 | Assistance Publique, Hopitaux De Paris | Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma |
| US6191123B1 (en) | 1999-03-19 | 2001-02-20 | Parker Hughes Institute | Organic-arsenic compounds |
| AU2001253919B2 (en) | 2000-04-26 | 2006-12-14 | Government Of The United States, D/B/A Department Of Veterans Affairs | Administration of a thiol-based chemoprotectant compound |
| DE10132625A1 (en) | 2001-07-05 | 2003-01-23 | Oce Printing Systems Gmbh | Process, computer program product and device system for visually checking image data |
| JP4571408B2 (en) | 2002-01-07 | 2010-10-27 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | S-dimethylarsino-thiosuccinic acid, S-dimethylarsino-2-thiobenzoic acid, S- (dimethylarsino) glutathione as cancer therapeutic agents |
| TW201350113A (en) * | 2004-07-16 | 2013-12-16 | Texas A & M Univ Sys | Organic arsenic compounds, uses of the same in treating cancer and pharmaceutical compositions comprising the same |
| EP1919564B1 (en) * | 2005-07-29 | 2014-11-26 | Ziopharm Oncology, Inc. | Compounds and methods for the treatment of cancer |
| EP1979368B1 (en) * | 2006-01-13 | 2014-12-24 | The Texas A&M University System | Compounds and methods for the treatment of cancer |
| TW200829261A (en) | 2006-09-29 | 2008-07-16 | Ziopharm Oncology Inc | Method for controlling angiogenesis in animals |
| US20090047243A1 (en) * | 2007-07-17 | 2009-02-19 | Richard Rickles | Combinations for the treatment of b-cell proliferative disorders |
| AU2008276451A1 (en) * | 2007-07-17 | 2009-01-22 | Zalicus Inc. | Treatments of B-cell proliferative disorders |
| KR20100100835A (en) * | 2007-11-02 | 2010-09-15 | 지오팜 온콜로지 인코포레이티드 | Combination therapy with organic arsenicals |
| WO2009151569A2 (en) * | 2008-06-09 | 2009-12-17 | Combinatorx, Incorporated | Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders |
-
2009
- 2009-08-14 JP JP2011523888A patent/JP5933896B2/en active Active
- 2009-08-14 EP EP09808635.8A patent/EP2321012B1/en active Active
- 2009-08-14 DK DK09808635.8T patent/DK2321012T3/en active
- 2009-08-14 KR KR1020177024240A patent/KR20170103023A/en active Application Filing
- 2009-08-14 KR KR1020187026317A patent/KR20180103194A/en not_active Application Discontinuation
- 2009-08-14 WO PCT/US2009/053858 patent/WO2010021928A1/en active Application Filing
- 2009-08-14 DK DK18174817.9T patent/DK3388111T3/en active
- 2009-08-14 MX MX2011001800A patent/MX2011001800A/en not_active Application Discontinuation
- 2009-08-14 EP EP18174817.9A patent/EP3388111B1/en active Active
- 2009-08-14 SG SG10201810450QA patent/SG10201810450QA/en unknown
- 2009-08-14 BR BRPI0918407A patent/BRPI0918407A2/en not_active Application Discontinuation
- 2009-08-14 US US13/059,176 patent/US20110269697A1/en not_active Abandoned
- 2009-08-14 KR KR1020117006250A patent/KR20110058818A/en active Search and Examination
- 2009-08-14 CA CA2734650A patent/CA2734650A1/en not_active Abandoned
- 2009-08-14 PT PT09808635T patent/PT2321012T/en unknown
- 2009-08-14 SG SG10201810449XA patent/SG10201810449XA/en unknown
- 2009-08-14 NZ NZ591181A patent/NZ591181A/en not_active IP Right Cessation
- 2009-08-14 ES ES18174817T patent/ES2901426T3/en active Active
- 2009-08-14 RU RU2011110392/14A patent/RU2534606C2/en active
- 2009-08-14 CN CN2009801356542A patent/CN102149432A/en active Pending
- 2009-08-14 SG SG10201403869TA patent/SG10201403869TA/en unknown
- 2009-08-14 AU AU2009282972A patent/AU2009282972A1/en not_active Abandoned
- 2009-08-14 ES ES09808635T patent/ES2703740T3/en active Active
- 2009-08-14 CN CN201410740427.5A patent/CN104800828A/en active Pending
- 2009-08-14 PT PT181748179T patent/PT3388111T/en unknown
-
2011
- 2011-02-10 IL IL211153A patent/IL211153A0/en unknown
- 2011-02-15 ZA ZA2011/01216A patent/ZA201101216B/en unknown
- 2011-11-14 HK HK18113573.8A patent/HK1254607A1/en unknown
-
2014
- 2014-05-26 JP JP2014108079A patent/JP5976036B2/en active Active
- 2014-10-27 US US14/524,586 patent/US10842769B2/en active Active
-
2015
- 2015-03-30 JP JP2015068284A patent/JP2015120755A/en not_active Withdrawn
-
2016
- 2016-01-07 HK HK16100117.0A patent/HK1212218A1/en unknown
- 2016-09-29 JP JP2016191062A patent/JP6315841B2/en active Active
-
2017
- 2017-12-19 JP JP2017242759A patent/JP2018039853A/en active Pending
-
2020
- 2020-10-15 US US17/071,623 patent/US11324714B2/en active Active
- 2020-10-15 US US17/071,435 patent/US11324713B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008079339A3 (en) | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections | |
| MX2009005649A (en) | Treatment for multiple myeloma. | |
| TW200744586A (en) | Therapeutic compounds | |
| WO2010093849A3 (en) | Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions | |
| MXPA05009694A (en) | Methods of improving skin quality. | |
| BRPI0413746A (en) | compound or a n-oxide thereof or pharmaceutically acceptable salt thereof, composition, and method of treating hyperproliferative disorder | |
| NZ580226A (en) | Dimer compounds as inhibitors of iap | |
| WO2009026176A3 (en) | Antiinfective flavononol compounds and methods of use thereof | |
| GEP20125643B (en) | Aurora kinase modulators and method of using same | |
| TW200510333A (en) | Benzimidazole compounds | |
| EA201000895A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIZOSOME DISEASES | |
| HK1085675A1 (en) | Anticancer compounds | |
| BRPI0413740A (en) | compound or a n-oxide thereof or pharmaceutically acceptable salt thereof, composition, and method of treating hyperproliferative disorder | |
| ATE511835T1 (en) | BIOPHOSPHONATES FOR THE TREATMENT OF ENDOMETRIOSIS | |
| TW200510317A (en) | Caspase inhibitors and uses thereof | |
| SG10201810449XA (en) | Organoarsenic compounds and methods for the treatment of cancer | |
| TW200613292A (en) | Benzothiazolium compounds | |
| MX2010008226A (en) | Difluorobiphenylamide derivatives for the treatment of ocular hypertension. | |
| UA107562C2 (en) | METHOD OF TREATMENT OF PSORIASIS | |
| EA200701852A1 (en) | DERIVATIVES OF AMINO ACIDS | |
| EA201170344A1 (en) | AZAINDOL IAP INHIBITORS | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
| IL165259A (en) | Compounds useful in the treatment of anthrax and inhibiting lethal factor | |
| TW200600084A (en) | Anti-coronavirus compounds |